Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
34.56
-1.07 (-3.00%)
At close: Jun 13, 2025, 4:00 PM
34.01
-0.55 (-1.59%)
After-hours: Jun 13, 2025, 5:34 PM EDT
Immunocore Holdings Stock Forecast
Stock Price Forecast
According to 8 professional analysts, the 12-month price target for Immunocore Holdings stock ranges from a low of $24 to a high of $100. The average analyst price target of $58.13 forecasts a 68.20% increase in the stock price over the next year.
Price Target: $58.13 (+68.20%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Immunocore Holdings stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 6 | 6 | 5 | 5 | 4 | 4 |
| Hold | 4 | 4 | 4 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 13 | 13 | 12 | 12 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +189.35% | Jun 2, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $85 → $86 | Buy | Maintains | $85 → $86 | +148.84% | May 8, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $54 → $50 | Buy | Maintains | $54 → $50 | +44.68% | Apr 14, 2025 |
| Needham | Needham | Strong Buy Reiterates $71 | Strong Buy | Reiterates | $71 | +105.44% | Apr 10, 2025 |
| Mizuho | Mizuho | Hold Maintains $38 → $33 | Hold | Maintains | $38 → $33 | -4.51% | Apr 7, 2025 |
Financial Forecast
Revenue This Year
393.40M
from 310.20M
Increased by 26.82%
Revenue Next Year
425.47M
from 393.40M
Increased by 8.15%
EPS This Year
-1.02
from -1.02
EPS Next Year
-1.31
from -1.02
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 538.2M | 566.9M | 608.6M | ||
| Avg | 393.4M | 425.5M | 495.8M | ||
| Low | 356.9M | 363.2M | 325.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 73.5% | 44.1% | 43.0% | ||
| Avg | 26.8% | 8.2% | 16.5% | ||
| Low | 15.1% | -7.7% | -23.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.21 | -0.11 | 1.16 | ||
| Avg | -1.02 | -1.31 | -0.54 | ||
| Low | -2.50 | -2.64 | -4.20 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.